SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH)

40 filings reported holding SOPH - SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share as of Q1 2025.
SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 23.3M shares of 66.4M outstanding shares and own 35.01% of the company stock.
Largest 10 shareholders include UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (7.63M shares), GENERATION INVESTMENT MANAGEMENT LLP (6.79M shares), AKRE CAPITAL MANAGEMENT LLC (2.24M shares), BANQUE PICTET & CIE SA (2.21M shares), Alta Wealth Advisors LLC (1.41M shares), PRINCIPAL FINANCIAL GROUP INC (1.39M shares), MILLENNIUM MANAGEMENT LLC (539K shares), Bank Pictet & Cie (Europe) AG (255K shares), EDMOND DE ROTHSCHILD HOLDING S.A. (203K shares), and FEDERATED HERMES, INC. (189K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.